期刊文献+

Oligonucleotide delivery by chitosan-functionalized porous silicon nanoparticles 被引量:2

Oligonucleotide delivery by chitosan-functionalized porous silicon nanoparticles
原文传递
导出
摘要 Porous silicon nanoparficles (pSiNPs) are a promising nanocarrier system for drug delivery owing to their biocompatibility, biodegradability, and non-inflammatory nature. Here, we investigate the fabrication and characterization of thermally hydrocarbonized pSiNPs (THCpSiNPs) and chitosan-coated THCpSiNPs for therapeutic oligonucleotide delivery. Chitosan coating after oligonucleotide loading significantly improves sustained oligonucleotide release and suppresses burst release effects. Moreover, cellular uptake, endocytosis, and cytotoxicity of oligonucleotide-loaded THCpSiNPs have been evaluated in vitro. Standard cell viability assays demonstrate that cells incubated with the NPs at a concentration of 0.1 mg/mL are 95% viable. In addition, chitosan coating significantly enhances the uptake of oligonucleotide-loaded THCpSiNPs across the cell membrane. Moreover, histopathological analysis of liver, kidney, spleen, and skin tissue collected from mice receiving NPs further demonstrates the biocompatible and non-inflammatory properties of the NPs as a gene delivery vehicle for intravenous and subcutaneous administration in vivo. Taken together, these results suggest that THCpSiNPs provide a versatile platform that could be used as efficient vehicles for the intracellular delivery of oligonucleotides for gene therapy. 多孔的硅 nanoparticles (pSiNPs ) 是为由于他们的 biocompatibility, biodegradability,和非煽动性的自然的药交货的一个有希望的 nanocarrier 系统。这里,我们调查制造和描述热地 hydrocarbonized pSiNPs (THCpSiNPs ) 和为治疗学的 oligonucleotide 的 chitosan 涂的 THCpSiNPs 交货。在显著地装载的 oligonucleotide 以后的 Chitosan 涂层改进持续 oligonucleotide 版本并且压制爆炸版本效果。而且,装载 oligonucleotide 的 THCpSiNPs 的细胞的举起, endocytosis,和 cytotoxicity 在 vitro 被评估了。标准房间生存能力试金证明在 0.1 mg/mL 的集中与 NP 孵化的房间是 95% 可行。另外, chitosan 涂层显著地越过房间膜提高装载 oligonucleotide 的 THCpSiNPs 的举起。而且,肝,肾,怒气,和皮组织的组织病理学说的分析从进一步收到 NP 的老鼠收集了在 vivo 为静脉内、下的管理作为基因交货车辆表明 biocompatible 和 NP 的非煽动性的性质。一起拿,这些结果建议 THCpSiNPs 提供能为基因治疗为 oligonucleotides 的细胞内部的交货被用作有效车辆的一个万用的平台。
出处 《Nano Research》 SCIE EI CAS CSCD 2015年第6期2033-2046,共14页 纳米研究(英文版)
关键词 NANOPARTICLES porous silicon CHITOSAN gene delivery 壳聚糖涂膜 寡核苷酸 纳米粒子 多孔硅 交付 功能化 生物相容性 细胞摄取
  • 相关文献

参考文献53

  • 1Patil, S. D.; Rhodes, D. G.; Burgess, D. J. DNA-based therapeutics and DNA delivery systems: A comprehensive review. AAPSL 2005, 7, E61-E77.
  • 2Helleday, T.; Petermann, E.; Lundin, C.; Hodgson, B.; Sharma, R. A. DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer 2008, 8, 193-204.
  • 3Blechinger, J.; Bauer, A. T.; Torrano, A. A.; Gorzelanny, C., Br/iuchle, C.; Schneider, S. W. Uptake kinetics and nano- toxicity of silica nanoparticles are cell type dependent. Small 2013, 9, 3970-3980.
  • 4Pendergrast, P. S.; Marsh, H. N.; Grate, D.; Healy, J. M.; Stanton, M. Nucleic acid aptamers for target validation and therapeutic applications. J. Biomol. Tech. 20115, 16, 224-234.
  • 5Niidome, T., Huang, L. Gene therapy progress and prospects: Nonviral vectors. Gene Ther. 2002, 9, 1647-1652.
  • 6Herweijer, H.; Wolff, J. A. Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther. 2003, 10, 453-458.
  • 7E1-Aneed, A. An overview of current delivery systems in cancer gene therapy. J. Control Release 2004, 94, 1-14.
  • 8Wong, S. Y.; Pelet, J. M.; Putnam, D. Polymer systems for gene delivery--Past, present, and future. Prog. Polym. Sci. 2007, 32, 799-837.
  • 9Thomas, C. E.; Ehrhardt, A.; Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4, 346-358.
  • 10Marshall, E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286, 2244-2245.

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部